6.
Desmet V
. What is congenital hepatic fibrosis?. Histopathology. 1992; 20(6):465-77.
DOI: 10.1111/j.1365-2559.1992.tb01031.x.
View
7.
Raj S, Singh R, Das P
. Mutational screening of PKD1 and PKD2 in Indian ADPKD patients identified 95 genetic variants. Mutat Res. 2020; 821:111718.
DOI: 10.1016/j.mrfmmm.2020.111718.
View
8.
Hogan M, Abebe K, Torres V, Chapman A, Bae K, Tao C
. Liver involvement in early autosomal-dominant polycystic kidney disease. Clin Gastroenterol Hepatol. 2014; 13(1):155-64.e6.
PMC: 4267913.
DOI: 10.1016/j.cgh.2014.07.051.
View
9.
Kanaheswari Y, Hamzaini A, Wong S
. Congenital hepatic fibrosis in a child with autosomal dominant polycystic kidney disease. Med J Malaysia. 2009; 63(3):251-3.
View
10.
Parkash A, Cheema H, Malik H, Fayyaz Z
. Congenital hepatic fibrosis: clinical presentation, laboratory features and management at a tertiary care hospital of Lahore. J Pak Med Assoc. 2016; 66(8):984-8.
View
11.
Farahmand F, Soleimani K, Hashemi M, Shafieyoun A, Rezaei N, Yousefi A
. Familial congenital hepatic fibrosis: report of a family with three affected children. Acta Med Iran. 2013; 51(9):655-6.
View
12.
Verbeeck S, Mekhali D, Cassiman D, Maleux G, Witters P
. Long-term outcome of transjugular intrahepatic portosystemic shunt for portal hypertension in autosomal recessive polycystic kidney disease. Dig Liver Dis. 2018; 50(7):707-712.
DOI: 10.1016/j.dld.2018.03.009.
View
13.
Lee F, Paes A
. Congenital hepatic fibrosis and adult-type autosomal dominant polycystic kidney disease in a child. Postgrad Med J. 1985; 61(717):641-2.
PMC: 2418332.
DOI: 10.1136/pgmj.61.717.641.
View
14.
Misra A, Loyalka P, ALVA F
. Portal hypertension due to extensive hepatic cysts in autosomal dominant polycystic kidney disease. South Med J. 1999; 92(6):626-7.
DOI: 10.1097/00007611-199906000-00015.
View
15.
Zhu B, Du Z, Wang Z, Li Y, Zhang J, Zhu H
. Congenital Hepatic Fibrosis in Children and Adults: Clinical Manifestations, Management, and Outcome-Case Series and Literature Review. Gastroenterol Res Pract. 2020; 2020:8284274.
PMC: 7191434.
DOI: 10.1155/2020/8284274.
View
16.
Arnold H, Harrison S
. New advances in evaluation and management of patients with polycystic liver disease. Am J Gastroenterol. 2005; 100(11):2569-82.
DOI: 10.1111/j.1572-0241.2005.00263.x.
View
17.
Gentile M, Di Carlo A, Susca F, Gambotto A, Caruso M, Panella C
. COACH syndrome: report of two brothers with congenital hepatic fibrosis, cerebellar vermis hypoplasia, oligophrenia, ataxia, and mental retardation. Am J Med Genet. 1996; 64(3):514-20.
DOI: 10.1002/(SICI)1096-8628(19960823)64:3<514::AID-AJMG13>3.0.CO;2-O.
View
18.
Cobben J, Breuning M, Schoots C, Ten Kate L, Zerres K
. Congenital hepatic fibrosis in autosomal-dominant polycystic kidney disease. Kidney Int. 1990; 38(5):880-5.
DOI: 10.1038/ki.1990.286.
View
19.
Spahiu L, Behluli E, Grajcevci-Uka V, Liehr T, Temaj G
. Joubert syndrome: Molecular basis and treatment. J Mother Child. 2023; 26(1):118-123.
PMC: 10032320.
DOI: 10.34763/jmotherandchild.20222601.d-22-00034.
View
20.
Chen I, Whitney-Miller C, Liao X
. Congenital hepatic fibrosis and its mimics: a clinicopathologic study of 19 cases at a single institution. Diagn Pathol. 2021; 16(1):81.
PMC: 8406726.
DOI: 10.1186/s13000-021-01142-y.
View